-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Galera Therapeutics, Inc. quarterly and annual Depreciation, Depletion and Amortization history and change rate from 2020 to Q1 2025.
- Galera Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
- Galera Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $20,000, a 92% decline from 2023.
- Galera Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $259,000, a 127% increase from 2022.
- Galera Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $114,000, a 85% decline from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)